These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 852314)

  • 21. Cost effectiveness of population screening and rescreening for cervical cancer in the Netherlands.
    Boon ME; de Graaff Guilloud JC
    Acta Cytol; 1981; 25(5):539-42. PubMed ID: 6792845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating and planning screening programmes.
    Parkin DM; Day NE
    IARC Sci Publ; 1985; (66):45-63. PubMed ID: 4093187
    [No Abstract]   [Full Text] [Related]  

  • 23. Cervical cancer screening in primary care: issues and recommendations.
    Mandelblatt J
    Prim Care; 1989 Mar; 16(1):133-55. PubMed ID: 2649899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population screening for cervical carcinoma in Frederiksberg borough: results of second and third rescreenings, 1966-1972.
    Gad C; Koch F
    Dan Med Bull; 1973 Oct; 20(5):141-3. PubMed ID: 4770766
    [No Abstract]   [Full Text] [Related]  

  • 25. Population screening for cervical carcinoma in Ostergötland.
    Sjöstedt S
    Acta Obstet Gynecol Scand; 1969; 48():Suppl 3:62. PubMed ID: 5380827
    [No Abstract]   [Full Text] [Related]  

  • 26. Epidemiologic characteristics in patients with epithelial dysplasi, carcinoma in situ, and invasive carcinoma of the uterine cervix. The population screening for cervical carcinoma in Maribo amt (county) 1967-1969.
    Berget A
    Dan Med Bull; 1975 Sep; 22(6):252-9. PubMed ID: 1175395
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cancer of the uterine cervix diagnosed from 1950 to 1960 in the municipality of Frederiksberg. A clinical review with follow-up for 10-19 years].
    Gad C; Ostergaard E
    Ugeskr Laeger; 1972 Mar; 134(12):601-10. PubMed ID: 5017118
    [No Abstract]   [Full Text] [Related]  

  • 28. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
    Wong G; Howard K; Webster A; Chapman JR; Craig JC
    Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A screening programme for cervical cancer that worked.
    Hakama M; Louhivuori K
    Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bleeding disorders. Screening for cancer of the uterine cervix].
    Kirt B
    Sygeplejersken; 1993 Jun; 93(26):12. PubMed ID: 8140514
    [No Abstract]   [Full Text] [Related]  

  • 31. ["Cost-effectiveness" of cervical screening].
    Kostova P
    Akush Ginekol (Sofiia); 2007; 46(6):32-4. PubMed ID: 17974169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vaginal cytological examination in the County of Arhus. Extent of screening in a county without a systematic screening program].
    Olesen F
    Ugeskr Laeger; 1984 Jul; 146(31):2325-9. PubMed ID: 6515834
    [No Abstract]   [Full Text] [Related]  

  • 33. [Population screening for cervix carcinoma in the city of Rotterdam, 1st round].
    van der Lee-Bijlsma A
    Ned Tijdschr Geneeskd; 1981 Dec; 125(49):2012-5. PubMed ID: 7322220
    [No Abstract]   [Full Text] [Related]  

  • 34. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The costs of cancer screening (author's transl)].
    Neumann G
    Geburtshilfe Frauenheilkd; 1975 Aug; 35(8):615-8. PubMed ID: 1175903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cervical cancer screening in Scandinavia.
    Day NE
    Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical carcinoma in Nigeria--a need for early detection.
    Edozien LC; Adewole IF
    Afr J Med Med Sci; 1993 Dec; 22(4):87-92. PubMed ID: 7839937
    [No Abstract]   [Full Text] [Related]  

  • 40. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.